• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

X4 Pharmaceuticals, Inc. - Common Stock (NQ:XFOR)

2.940 -0.120 (-3.92%)
Streaming Delayed Price Updated: 3:56 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about X4 Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
12 Health Care Stocks Moving In Friday's Intraday Session
April 26, 2024
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 21, 2024
 
Via Benzinga
XFOR Stock Earnings: X4 Pharmaceuticals Beats EPS for Q4 2023
March 21, 2024
XFOR stock results show that X4 Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 11, 2023
Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the... 
Via Benzinga
Recap: X4 Pharmaceuticals Q3 Earnings
November 09, 2023
 
Via Benzinga
Earnings Outlook For X4 Pharmaceuticals
November 08, 2023
 
Via Benzinga
Earnings Scheduled For November 13, 2024
November 13, 2024
 
Via Benzinga
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
June 24, 2024
Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
May 09, 2024
Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday! 
Via InvestorPlace
XFOR Stock Earnings: X4 Pharmaceuticals Misses EPS for Q1 2024
May 07, 2024
XFOR stock results show that X4 Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
FDA Approves X4 Pharmaceuticals' Mavorixafor As First Therapy For Rare Immunodeficiency Disorder
April 29, 2024
FDA approves Xolremdi capsules for WHIM syndrome, boosting neutrophil & lymphocyte counts. First therapy for this rare immunodeficiency disorder. Potential sales forecasted at $54.6M in 2024, rising to... 
Via Benzinga
Recap: X4 Pharmaceuticals Q4 Earnings
March 21, 2024
 
Via Benzinga
X4 Pharmaceuticals's Earnings Outlook
March 20, 2024
 
Via Benzinga
Undervalued Stocks to Watch After X4 Pharma (NASDAQ:XFOR) News: KAVL, HNRC, AYRO, VVPR
May 18, 2023
Via AB Newswire
Earnings Scheduled For March 21, 2024
March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 11, 2023
 
Via Benzinga
What 5 Analyst Ratings Have To Say About X4 Pharmaceuticals
May 05, 2023
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 11, 2023
 
Via Benzinga
Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket
December 11, 2023
Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
December 11, 2023
It's time to start the trading week with a look at the biggest pre-market stock movers worth watching for Monday morning! 
Via InvestorPlace
Earnings Scheduled For November 9, 2023
November 09, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 11, 2023
 
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
August 11, 2023
Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
August 10, 2023
 
Via Benzinga
Oracle And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
June 13, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. SunCar Technology Group Inc. (NASDAQ: SDA) shares jumped 31.2% to $22.13... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 17, 2023
 
Via Benzinga
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
August 10, 2023
Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results. 
Via Benzinga
X4 Pharma Highlights 'Significant Reduction' Rate In Severity, Duration Of Infections
May 17, 2023
X4 Pharmaceuticals Inc (NASDAQ: XFOR) highlighted new data from a Phase 3 clinical trial of once-daily, oral mavorixafor in  
Via Benzinga
Earnings Scheduled For August 10, 2023
August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
Earnings Scheduled For May 4, 2023
May 04, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Recent Quotes
View More
Symbol Price Change (%)
GOOG  246.17
+1.53 (0.63%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap